FreshLeaf reveals medicinal cannabis report
FreshLeaf Analytics has released a comprehensive report on the current status of the Australian medicinal cannabis market

FreshLeaf reveals medicinal cannabis report

FreshLeaf Analytics has released a comprehensive report on the current status of the Australian medicinal cannabis market. The FreshLeaf H1 2021 product, pricing and patient analysis report found that the last six months were defined by intense medicinal cannabis product competition, keeping downward pressure on prices. The report has also been welcomed by the sector.

Cassandra Hunt, Managing Director of FreshLeaf, said, “The Australian medicinal cannabis market continues its strong growth trajectory, with revenue expected to more than double in 2021 from around $100 million last year. There’s good news for patients, too, with the price of medicine continuing to fall.”

The number of patients taking medicinal cannabis has grown by a factor of 15x over the past two years, with a significant increase in authorised prescribers noted in the report.

Leave a Reply